Top compounds associated with response to NHS


Feature Type Standardized
Nominal ANOVA
mRNA cyanoquinoline 11 CTRPv2 pan-cancer AAC -0.14 0.008
mRNA CGP-082996 GDSC1000 pan-cancer AAC -0.16 0.009
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.091 0.01
mRNA AEW541 CCLE pan-cancer AAC -0.13 0.01
mRNA AT-7519 GDSC1000 pan-cancer AAC 0.08 0.01
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.094 0.01
mRNA TKI258 CCLE pan-cancer AAC -0.13 0.01
mRNA BRD-K48477130 CTRPv2 pan-cancer AAC 0.14 0.01
mRNA fingolimod CTRPv2 pan-cancer AAC -0.092 0.01
mRNA BMS-345541 CTRPv2 pan-cancer AAC -0.093 0.01
Download CSV